NasdaqGS - Nasdaq Real Time Price USD
Tarsus Pharmaceuticals, Inc. (TARS)
49.97
+0.53
+(1.08%)
As of 1:07:28 PM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-83,027
-83,027
-117,493
-49,030
3,748
Investing Cash Flow
-199,195
-199,195
140,604
-144,629
-586
Financing Cash Flow
154,656
154,656
130,176
93,987
21
End Cash Position
97,381
97,381
224,947
71,660
171,332
Interest Paid Supplemental Data
7,662
7,662
2,880
1,675
--
Capital Expenditure
-6,567
-6,567
-5,502
-506
-586
Issuance of Capital Stock
98,287
98,287
118,599
74,352
--
Issuance of Debt
75,000
75,000
10,000
20,000
--
Free Cash Flow
-89,594
-89,594
-122,995
-49,536
3,162
12/31/2021 - 10/16/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SWTX SpringWorks Therapeutics, Inc.
40.87
+0.91%
CYTK Cytokinetics, Incorporated
38.73
+2.43%
EWTX Edgewise Therapeutics, Inc.
14.69
+8.58%
PTGX Protagonist Therapeutics, Inc.
46.28
+0.93%
KRYS Krystal Biotech, Inc.
167.99
-0.48%
DAWN Day One Biopharmaceuticals, Inc.
7.54
+2.86%
ARQT Arcutis Biotherapeutics, Inc.
14.48
+4.66%
SPRY ARS Pharmaceuticals, Inc.
14.68
-2.13%
BPMC Blueprint Medicines Corporation
85.39
+2.37%
MLTX MoonLake Immunotherapeutics
40.24
+2.00%